Completed PHASE1 INTERVENTIONAL 4-arm NCT01141504

Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance

Effect of Oral ATP on Human Muscle Performance

Sponsor: Iowa State University

Interventions PeakATP 250 PeakATP 400 PeakATP 400 plus proprietary blend Placebo

Updated 5 times since 2017 Last updated: Jan 9, 2012 Started: Jun 30, 2010 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy Subjects, this trial is completed. The trial is conducted by Iowa State University and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Iowa State University
Metabolic Technologies Inc.

Data source: Metabolic Technologies Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ames, United States